Mortality and Morbidity in HFrEF, HFmrEF, and HFpEF Patients with Diabetes in the Middle East
Mohammed Al‐Jarallah, Rajesh Rajan, Ibrahim Al‐Zakwani, Raja Dashti, Bassam Bulbanat, Mustafa Ridha, Kadhim Sulaiman, Alawi Alsheikh‐Ali, Prashanth Panduranga, Khalid F. AlHabib, Jassim Al Suwaidi, Wael Almahmeed, Hussam AlFaleh, Abdelfatah Elasfar, Ahmed Al‐Motarreb, Nooshin Bazargani, Nidal Asaad, Haitham Amin
Abstract
OBJECTIVES: We sought to estimate the mortality and morbidity in diabetic acute heart failure (AHF) patients stratified by left ventricular ejection fraction. METHODS: We analyzed the data of patients with AHF from seven Middle Eastern countries (Bahrain, Oman, Yemen, Kuwait, UAE, Qatar, and Saudi Arabia) from February to November 2012, who were enrolled in a multinational registry of patients with heart failure (HF). RESULTS: 0.335). CONCLUSIONS: EF. However, there were no significant differences in mortality at one-year follow-up between the HF groups. There were also no significant differences in re-hospitalization rates between the HF groups not only at three months but also at one-year follow-up in the Middle East.